Physician profile
Michael Reed
NPI 1558740266
$3,132.08
in general payments reported to CMS, 2019-2025
17 companies · $841 in 2025
The $841 reported for 2025 was more than what 77% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,301 · 2020: $568 · 2021: $14.95 · 2022: $12.63 · 2023: $59.77 · 2024: $334 · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $890 · Travel and Lodging: $322 · Consulting Fee: $23.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $889.87 |
| Travel and Lodging | $321.90 |
| Consulting Fee | $23.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Goode Surgical INC | $1,150.49 | 2019 | |
| Steelhead Surgical INC | $499.61 | 2020 | |
| Arthrex, INC. | $484.90 | 2025 | |
| Kerecis Limited | $212.91 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Averitas Pharma INC. | $193.74 | 2024-2025 | Qutenza |
| Smith+Nephew, INC. | $161.95 | 2019-2025 | Healicoil, Bone Anchors With Arthroscopic Delivery System, Footprint |
| Bone Support INC. | $144.34 | 2025 | Ceramentbone Void Filler, Cerament G |
| Horizon Therapeutics Plc | $54.26 | 2019 | |
| Stryker Corporation | $45.65 | 2025 | Prostep, Ortholoc 2 Lapifuse, Prostep Mica |
| Organogenesis INC. | $38.99 | 2023-2025 | Affinity, Puraply |
| Merck Sharp & Dohme LLC | $33.47 | 2019 | |
| Bioventus LLC | $25.78 | 2019 | |
| Next Science LLC | $23.16 | 2024 | Surgx, Blastx, Xperience |
| Cardiovascular Systems INC. | $21.15 | 2020 | |
| Cgg Medical INC | $14.58 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $14.47 | 2019 | |
| Stimwave Technologies Incorporated | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.